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Introduction 
 
Cancers of the head and neck require utmost attention due 
to their special anatomical location, their effect on facial 
appearance, their hidden nature and complex treatment.
1
 
Squamous cell carcinoma (SCC) is the most common 
cancer occurring in the head and neck region.
2
 SCC is the 
sixth most common cancer in males and the 15
th
 most 
common cancer in females.
3
 SCC of the head and neck was 
ranked eighth in terms of cancer mortality worldwide in 
2008.
4
 The incidence of oral cancer is high in developing 
countries and it has been reported that two-thirds of new 
patients are detected in developing countries.
5
 Oral cancer 
is reportedly the most common malignancy after the 
cervical and stomach cancer in developing countries.
5
 The 
recognized risk factors for SCC include cigarette smoking, 
tobacco use (chewing/smoking), alcohol consumption 
accompanied by smoking, exposure to carcinogens such as 
food preservatives, phenols, air pollutants, hazardous 
radiations such as UV and X-ray radiation, infections such 
as syphilis, infection with human papilloma virus or 
Candida albicans and malnutrition.
6,7
  
 
The signs and symptoms of oral squamous cell carcinoma 
(OSCC) often include presence of a white, red or mixed 
white and red plaques, an ulcer with prominent, rigid 
margins, pain, burning sensation or paresthesia at the site 
and a prominent fungus- or cauliflower-shaped mass, which 
are detected during clinical oral examination. 
 
The blood groups are determined based on the 
presence/absence of some specific hereditary antigens on 
the surface of red blood cells. The A, B and AB antigens 
may be present on the surface of red blood cells. 
Accordingly, the blood groups A, B, AB or O are 
determined.
3
 These antigens are the most important human 
antigens extensively expressed and found in red blood 
cells, epithelial cells and body fluids.
7-9
 In other words, 
blood group antigens are among the easiest to find and 
most accessible expressed genes that can be quickly 
quantified in humans.
9
 These antigens may be related to 
different diseases since people with some specific antigens 
may be resistant to some and prone to some other 
conditions.
10-12
 However, this association has yet to be 
definitely confirmed.
10,13
 Immunohistochemical analyses 
have demonstrated loss of expression of A or B antigens in 
more than 80% of patients with OSCC. Similarly, 
potentially malignant lesions with epithelial dysplasia have 
also shown loss of expression of these antigens.
14,15
  
 
Some studies have pointed to the association of blood 
group antigens with cancers.
11,12
 Rios and Bianca
12
 reported 
that the frequency of blood group A was significantly 
higher in patients with cancer. They also showed that the 
Lewis antigen was significantly associated with 
malignancy. Sharma et al.
11
 found a significant association 
between breast cancer and blood type A. Also, they 
reported that the frequency of blood types B and O was 
equally higher than other blood types in patients with 
cervical cancer. The blood type B was predominant in 
patients with oral mucosal cancer. Xu et al.
13
 found a 
significant association between blood type A and 
endometrial carcinoma. According to Jaleel et al.,
5
 people 
with blood type A have 1.46 times higher risk of 
developing oral cancer. However, according to Xie et al.,
16
 
the correlation of blood type and risk of cancer varies 
depending on the race and ethnicity of patients. But, 
adequate evidence is still lacking in this respect.
14,15
 
Considering the gap of information regarding the 
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association of blood group and OSCC in Iran, this study 
aimed to assess the ABO blood group distribution in 
patients with OSCC.   
 
Materials and Method 
 
This descriptive, analytical study evaluated 113 patients 
complaining of oral lesions presenting to Imam Reza and 
Sina Hospitals in Tabriz and Dental School of Tabriz 
University of Medical Sciences from 2011 to 2014, for 
whom, a definite diagnosis of OSCC was made. The study 
was approved in the ethics committee of Qazvin University 
of Medical sciences (code: IR.QUMS.REC.1395.4). 
Written informed consent was obtained from all patients 
and they were ensured about the confidentiality of their 
information.  
 
The inclusion criterion was confirmed diagnosis of OSCC. 
The exclusion criteria were unwillingness to participate in 
the study, tobacco use, alcohol consumption and history of 
chemotherapy or radiotherapy.  
 
The age and sex of patients, location of the lesion and 
family history of cancer were recorded. The blood type of 
patients was determined according to their blood card or by 
blood typing. Our control group included 2000 blood 
donors with no systemic disease. The blood type of control 
subjects was also recorded.  
 
Data were analyzed using SPSS version 16 (SPSS Inc., IL, 
USA) via analytical (chi-square test and t-test) or 
descriptive (mean and standard deviation) statistics. Level 
of significance was set at 0.05. 
 
Results 
 
A total of 133 patients with OSCC were evaluated 
including 94 males (70.7%) and 39 females (29.3%). The 
mean age of patients was 67.51±14.29 years (range 30 to 
70 years). Of all, 32 patients (24.1%) were in the age range 
of 60 to 70 years.  
 
Figure 1 shows the age distribution of patients.  
 
 
 
Figure 1: Age distribution of patients 
 
 
 
Figure 2: Frequency distribution of patients according to 
the locations of OSCC 
 
Figure 2 shows the frequency distribution of patients 
according to the location of OSCC. Lip was the most 
common site of involvement (n=61, 45.9%). 
 
Regarding the family history of cancer, 23 patients (17.3%) 
had a positive family history of SCC. Follow-up of patients 
revealed that 82 patients (61.7%) were cured, 16 (12%) had 
severe complications, 9 (6.7%) had mild complications and 
26 (19.6%) were deceased.  
 
Figure 3 shows the frequency distribution of different blood 
types. Blood type A (n=45, 33.8%) was the most common 
blood type.  
 
 
 
Figure 3: Frequency distribution of different blood types 
 
Comparison of frequency distribution of blood types of 
controls with patients revealed that the frequency of AB 
blood type was significantly higher in patients with OSCC 
while the frequency of O blood type was significantly 
lower among OSCC patients compared to healthy controls. 
Table 1 shows the correlation of blood type with 
occurrence of OSCC. The correlation of occurrence of 
OSCC with blood type O was evaluated and the results 
showed that OSCC patients had a significantly lower 
frequency of this blood type (P=0.001, OR at 95% 
CI=0.480). The correlation of occurrence of OSCC with 
blood type A was evaluated and the results showed that 
OSCC patients had higher a frequency of this blood type 
but this difference was not statistically significant 
(P=0.927, OR at 95% CI=1.017). The correlation of 
occurrence of OSCC with B blood type was evaluated and 
the results showed that OSCC patients had higher 
frequency of this blood type but this difference was not 
statistically significant (P=0.175, OR at 95% CI=1.309). 
 
 
 
Table 1: Correlation of blood tye with occurence of OSCC 
 
Discussion 
 
This study assessed the ABO blood group distribution in 
patients with OSCC and showed that blood type A was the 
most common (33.8%) among OSCC patients. The 
frequency of blood type AB was significantly higher while 
the frequency of blood type O was significantly lower in 
OSCC patients compared to controls. In this study, 133 
patients (70.7% males, 29.3% females) with a mean age of 
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67.51 years were evaluated. Of all patients, 24.1% were in 
the age range of 60 to 70 years.  
 
The study of Sharma et al.
11
 was conducted on 82 patients 
with buccal cancer.  Akhtar et al.
9 
evaluated 560 patients 
with oral cancer (44% males, 56% females) and 2,640 
healthy controls. Gao et al.
14
 evaluated 24 OSCC patients 
(70% males and 30% females) with a mean age of 56.29 
years. Jaleel et al.
6
 studied 235 oral cancer patients (32% 
males, 68% females) that were mostly between 40 to 59 
years. They showed that females were significantly more 
affected than males. Mortazavi et al.
1
 evaluated 104 
patients (66% males, 34% females) and 90 healthy controls. 
In the patient group, 25% were under 50 years of age while 
75% were older than 50 years. Cawson et al.
17
 reported that 
oral cancer was age-dependent and 98% of patients in their 
study were older than 40 years. In the study by Razavi et 
al.,
18
 55% of patients were males and 45% were females 
with a mean age of 52 years. Our results showed higher 
frequency of OSCC in males, which was in agreement with 
the findings of Gao et al.,
14
 Mortazavi et al.,
1
 Cawson et 
al.,
17
 and Razavi et al.
18
 This finding may be due to higher 
frequency of cigarette smoking and tobacco chewing in 
males and greater exposure to carcinogens in the work 
environment. Higher frequency of involvement of females 
in some studies
6,9
 may be related to different lifestyle of 
women such as higher prevalence of cigarette smoking 
among them or exposure to carcinogens.  
 
In our study, the lips were the most common site of 
involvement followed by the tongue. In the study by Gao et 
al.
14
 tongue was the most common site of involvement 
(30%) followed by the buccal mucosa (20%). In the study 
by Jaleel et al.
6
 buccal mucosa was the most common site 
of involvement (68%) followed by the tongue (12%), palate 
(11%) and alveolar bone (12%). Involvement of the lips 
had the lowest frequency (1%). Razavi et al.
18
 reported 
gingival involvement in 46%, tongue involvement in 18%, 
buccal mucosa involvement in 13%, involvement of the 
palate in 13% and involvement of the lips in 6%. 
Variability in the findings of studies regarding the most 
common site of involvement can be due to different 
etiologies of OSCC. Higher frequency of lip involvement 
in our study may suggest the role of sunlight and 
environmental factors in development of OSCC (instead of 
carcinogens or chewing tobacco).  
 
ABO and Lewis antigens on the membrane of red blood 
cells may undergo changes during maturation or malignant 
transformation (dysplastic changes) of cells. High 
incidence of some carcinomas has been reported in patients 
with A/B blood types, which may be due to high affinity of 
some microorganisms for these antigens, leading to 
development of malignancies.
15
 Several mechanisms have 
been suggested for the association of ABO blood group and 
occurrence of malignancies including inflammation, 
impaired immunity function in finding malignant cells, 
intracellular adhesion and intracellular signaling.
16
 Down-
regulation of glycosyltransferase in biosynthesis of A and B 
antigens can cause an imbalance between the expression of 
ABO genes and other genes and initiate carcinogenesis.
18,19
 
ABO antigens also play a role in function of key receptors 
such as EGF, integrin, cadherin and CD44 and regulate cell 
proliferation, adhesion and movement. Since the pattern of 
expression of these receptors widely varies in normal and 
cancer cells, role of ABO antigens is also widely variable 
in tumorigenesis.
20
 Risk of lip cancer, tongue cancer, 
gingival cancer, buccal mucosa cancer and carcinoma of 
the salivary glands is reportedly higher in patients with 
blood type A.
21
 Carcinoma of the salivary glands also 
occurs in patients with B blood type but with a lower 
prevalence.
21
 Subjects with blood type O are significantly 
resistant to this type of cancer.
21
 Esophageal and laryngeal 
cancers are more common in patients with blood types A 
and B but those with blood type O are relatively resistant to 
esophageal cancer.
21 
 
In our study, blood type A was the most common (33.8%) 
among OSCC patients. The results showed that the 
frequency of blood type AB was significantly higher while 
the frequency of blood type O was significantly lower in 
OSCC patients compared to controls. In the study by 
Sharma et al.,
11
 the frequency of blood type B was 
significantly higher among OSCC patients. Biondi et al.
20
  
reported higher prevalence of blood type O among patients 
with oral cancer. Jaleel et al.
6
 showed a significant 
correlation between oral cancer and blood type A (P<0.05, 
OR: 1.46). Mortazavi et al.
1
 demonstrated that oral cancer 
patients had significantly lower frequency of blood type O 
and higher frequency of blood type B compared to the 
control group. They also compared squamous cell and non-
squamous cell cancers and reported higher frequency of 
blood type B in patients with non-squamous cell cancer. 
Juvanovic-Cupic et al.
22
 stated that blood type B was more 
prevalent in patients with oral and gastrointestinal cancers. 
Gopal Reddy et al.
23
 reported that patients with blood 
group A had higher risk of developing oral submucous 
fibrosis, which is among the most common premalignant 
conditions in Indians. Saxena et al.
24 
evaluated the 
association of blood group with oral cancer in Western 
Rajasthan and found that blood group A had the strongest 
association with oral cancer followed by blood types O and 
B. Qin et al.
25 
demonstrated that the overall survival of 
patients with esophageal, SCC was significantly worse in 
patients with blood type AB compared to those with other 
blood groups. This was especially true in patients with 
negative lymph nodes.  A review article by Ramesh et al.
26
 
on studies regarding the association of blood group with 
oral cancer published between 1965 to 2015 concluded that 
an inherited element plays a role in susceptibility or 
resistance to different types of cancers. They added that 
racial and ethnic distribution of blood groups play a pivotal 
role in prediction of the risk of cancer. 
 
As shown by our results and those of the afore-mentioned 
studies, incidence of oral cancer seems to be significantly 
higher in non-O groups and presence of A and B antigens 
increases the risk of malignancy. Absence of these antigens 
(blood type O) decreases this risk. However, sample size, 
method of sampling, ethnicity and race of patients and 
Jalili L et al 
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frequency of different blood types in a population all affect 
the non-O blood type with the greatest association with 
development of cancer and explains the variability in 
results in this respect. 
 
Considering the obtained findings, blood typing can be 
used as a routine method to identify the susceptible 
individuals and counsel them to minimize the risk factors 
of OSCC in them as much as possible (i.e. by quitting 
smoking). Also, regular cancer screening should be 
scheduled for susceptible individuals. Future studies with 
larger sample size in different geographical areas are 
required to better elucidate this topic. Similar studies 
regarding the relationship of ABO blood group and other 
types of cancers are also recommended.   
 
Conclusion  
 
The results showed that presence of A and B antigens on 
cells may increase the risk of OSCC. Blood type O had a 
significantly lower and blood type AB had a significantly 
higher frequency among OSCC patients in our study 
compared to controls.  
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